Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A
J. Clin. Invest. Miho Nozaki, et al. 116:422 doi:10.1172/JCI26316 [Go to this article.]

Figure 5
VEGF-A increased CNV before injury via VEGFR-2. Injected 1 day before injury, VEGF-A (0.1 pmol), VEGF-E (0.11 pmol), and CoCl₂ (0.77 nmol), but not PlGF-1 (43.1 pmol), increased CNV. *P < 0.05 compared with PBS. n = 10 per data point.